Media
| Press Releases
KBP Biosciences Announces Support of Kidney Disease Clinical Trialists 2024 Work...
SINGAPORE,27 March2024 -- KBP Biosciences PTE. Ltd. (“KBP Biosciences” or the “Company”), a clinical...
Mar 27, 2024
KBP Biosciences Announces Completion of Enrollment to its Phase 3 CLARION-CKD St...
PRINCETON, N.J., 31 October 2023 -- KBP Biosciences PTE, Ltd. (“KBP Biosciences”), a clinical-stage ...
Nov 02, 2023
Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Biosc...
Bagsværd, Denmark and Singapore, 16 October 2023 – Novo Nordisk A/S and KBP Biosciences PTE., Ltd. t...
Oct 16, 2023
Ocedurenone: A Novel Therapy for Uncontrolled Hypertension in Advanced Chronic K...
EMJ Nephrology interviewed two World-renowned experts in nephrology and cardiology, George Bakris an...
Apr 18, 2023
KBP Biosciences Announces First Patient Dosed in China
PRINCETON, N.J., 31 March 2023 -- KBP Biosciences PTE. Ltd. (“KBP Biosciences” or the “Company”), a ...
Mar 31, 2023
Ocedurenone Featured at Kidney Disease Clinical Trialists 2023 Workshop: Insight...
PRINCETON, N.J., 17 March 2023 -- KBP Biosciences PTE. Ltd. (“KBP Biosciences” or the “Company”), a ...
Mar 17, 2023
Ocedurenone (KBP-5074) Featured at the 19th Cardiovascular Clinical Trialists Fo...
PRINCETON, N.J., 10 February 2023 -- KBP Biosciences PTE. Ltd. (“KBP Biosciences” or the “Company”),...
Feb 13, 2023
KBP Presents Ocedurenone Clinical Pharmacology Studies at ASN Kidney Week 2022
PRINCETON, N.J., 2 December2022 -- KBP Biosciences PTE. Ltd. (“KBP Biosciences” or the “Company”), a...
Dec 02, 2022
KBP Presents Ocedurenone Phase 2b Subgroup Analysis at AHA Scientific Sessions 2...
PRINCETON, N.J., 1 December 2022 -- KBP Biosciences PTE. Ltd. (“KBP Biosciences” or the “Company”), ...
Dec 01, 2022
KBP Presents Results of the Hepatic Impairment Study and Drug-Drug Interaction S...
PRINCETON, N.J., 30November2022 -- KBP Biosciences PTE. Ltd. (“KBP Biosciences” or the “Company”), a...
Nov 30, 2022
Announcement of Interim Chief Commercial Officer Appointment
PRINCETON, N.J., 15 November, 2022 -- KBP Biosciences Co., Ltd. (“KBP Biosciences” or “KBP” or the “...
Nov 16, 2022
Announcement of Deputy Chief Medical Officer Appointment
PRINCETON, N.J., 14 November 2022 -- KBP Biosciences Co., Ltd. (“KBP Biosciences” or “KBP” or the “C...
Nov 15, 2022